← back to search

Francesca Martinelli

University of Perugia · BE
Area of research
Oncology · Economics and Econometrics
Research interest
Research interests include Cancer survivorship and care, Health Systems, Economic Evaluations, Quality of Life, Economic and Financial Impacts of Cancer, and Global Cancer Incidence and Screening.
h-index
28
citations
3,195
works
100
NIH funding
primary concept
Medicine
email

Recent publications

Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study
EClinicalMedicine 2025cited by 15position: middledoi
EP17.06-01 COVID-19 Long-Lasting Effect on Lung Cancer Diagnoses in Italy: Update of the Real-World Multicenter COVID-DELAY Study
Journal of Thoracic Oncology 2023cited by 0position: middledoi
Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study
European Journal of Cancer 2022cited by 32position: middledoi
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period
Neuro-Oncology 2022cited by 18position: middledoi
Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients
Neuro-Oncology Practice 2020cited by 11position: middledoi
Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling
Neuro-Oncology Advances 2020cited by 3position: middledoi
Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer
European Journal of Cancer 2019cited by 75position: middledoi
Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?
Neuro-Oncology 2019cited by 70position: middledoi
The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials
European Journal of Cancer 2019cited by 39position: middledoi
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review
The Lancet Oncology 2018cited by 98position: middledoi
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials
Clinical Trials 2018cited by 48position: middledoi
The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients
European Journal of Cancer 2015cited by 148position: middledoi
The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative
JNCI Journal of the National Cancer Institute 2015cited by 37position: middledoi
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites
Cancer 2013cited by 202position: middledoi
An international study of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different cancer sites.
Journal of Clinical Oncology 2012cited by 2position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andrew Bottomley · European Organisation for Research and Treatment of Cancer13 papers (2012–2025)Corneel Coens · KU Leuven13 papers (2012–2025)Jaap C. Reijneveld · Academic Medical Center8 papers (2018–2025)Martin Taphoorn · Erasmus University Rotterdam7 papers (2012–2025)Hans‐Henning Flechtner · Otto-von-Guericke University Magdeburg7 papers (2012–2025)Linda Dirven · Erasmus MC6 papers (2018–2022)Jolie Ringash · Princess Margaret Cancer Centre6 papers (2012–2025)Galina Velikova · University of Leeds6 papers (2015–2025)Alba A. Brandes · AstraZeneca (Italy)5 papers (2019–2022)Marijke B Coomans · Erasmus University Rotterdam5 papers (2019–2022)Martin J. van den Bent · St James's University Hospital5 papers (2019–2022)Michael Weller · Center for Neurosciences5 papers (2019–2022)Thierry Gorlia · Aix-Marseille Université5 papers (2019–2022)Roger Stupp · Northwestern University5 papers (2019–2022) · 5 papers (2019–2022)Annika Malmström · Sunnybrook Health Science Centre5 papers (2019–2022) · 5 papers (2019–2022)Ulrich Herrlinger · Brain (Germany)5 papers (2019–2022)Chantal Quinten · European Centre for Disease Prevention and Control5 papers (2012–2018)Olivier Chinot · Peuplements végétaux et bioagresseurs en milieu tropical5 papers (2019–2022)